Clinical Trial Update: Immunotherapy Before Transplantation for Skin Cancer Prevention in Organ Transplant Recipients [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating immunotherapy before transplantation to prevent skin cancer in organ transplant recipients has been withdrawn, with endpoints focusin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Actinic Keratoses
• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• Immunotherapy (immunotherapy)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Cutaneous Squamous Cell Carcinoma, Actinic Keratoses | Phase 2 | Status: WITHDRAWN